Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

OSU Professor Helps Develop Promising Ebola Drug

November 11, 2014 10:39 am | News | Comments

As the Ebola crisis in Africa continues and concern ramps up in the United States, a pharmaceutical company with a Corvallis connection is ready to respond with a limited amount of a potentially promising new drug. Read more...


FDA Accepts Amgen's BLA for Cholesterol-Lowering Drug

November 11, 2014 10:27 am | News | Comments

Amgen announced that the U.S. Food and Drug Administration (FDA) has accepted for review Amgen's Biologics License Application (BLA) for evolocumab for the treatment of high cholesterol. Read more...


New Research Venture Aims to Lower Cost of Meds

November 11, 2014 10:22 am | News | Comments

Bath is the first institution outside the United States to receive funding from the US Food & Drugs Administration (FDA), for a major new research collaboration that will strive to open up the pharmaceutical drugs market and enable the design of better and cheaper medicines. Read more...


Google, CEO Donate to Ebola Fight

November 11, 2014 10:16 am | News | Comments

Google is launching a campaign to help fight Ebola by contributing $2 for every dollar people donate to a slew of nonprofits such as Save the Children and the Doctors Without Borders. Read more...


Gilead's Hep C Drug Gets Positive Results

November 11, 2014 10:09 am | News | Comments

Gilead Sciences Inc. announced results from several Phase 2 and Phase 3 studies evaluating investigational uses of Harvoni (ledipasvir 90 mg/sofosbuvir 400 mg) for the treatment of chronic hepatitis C virus (HCV) infection in patients with limited or no treatment options. Read more...


New Ebola Treatment Unit Opens in Liberia

November 10, 2014 3:07 pm | by Jonathan Paye-Layleh - Associated Press | News | Comments

The United States opened the first of 17 Ebola treatment units it is building in Liberia. Read more...                           


BI Launches Global Trial for Antidote in Patients Taking Pradaxa

November 10, 2014 2:14 pm | News | Comments

Boehringer Ingelheim announced the initiation of U.S. sites for a test trial revolving around a potential antidote for patients taking pradaxa. Read more...                  


Classifications of Gene Mutations in Children's Cancer May Lead to Better Treatments

November 10, 2014 2:02 pm | News | Comments

Oncology researchers studying gene mutations in the childhood cancer neuroblastoma are refining their diagnostic tools to predict which patients are more likely to respond to drugs. Read more...          


Dendreon Corporation Files for Bankruptcy

November 10, 2014 1:37 pm | by Tom Murphy - AP Business Writer | News | Comments

The company had high hopes for an innovative prostate cancer treatment but sales of the drug fell extremely short of expectations. Read more...                    


Lilly's Injectable Diabetes Drug is Now Available in US Pharmacies

November 10, 2014 1:18 pm | News | Comments

Eli Lilly's new type 2 diabetes drug arrives in US pharmacies today. Read more...                              


J&J Announces Completed Acquisition of Alios BioPharma

November 10, 2014 12:54 pm | News | Comments

Johnson & Johnson announced the completion of the acquisition of Alios BioPharma. Read more...                           


Scientists Find Protein That Could Improve Cancer Therapies

November 10, 2014 12:41 pm | News | Comments

UCLA scientists have discovered that a protein usually linked to rare neurological disorders is also associated with head and neck cancer. Read more...                  


Encycle Therapeutics to Develop Molecule to Tackle IBD

November 10, 2014 10:54 am | News | Comments

Encycle Therapeutics is working a lead molecule to combat inflammatory bowel disease. Read more...                           


BMS Announces High Cure Rates for Hepatitis C Drug

November 10, 2014 10:42 am | News | Comments

Bristol-Myers Squibb announced late-breaking data regarding a new drug combination for Hepatitis C patients. Read more...                       


Ebola Volunteers Wrestle With Quarantine Mandates

November 10, 2014 9:19 am | by Jennifer Peltz - Associated Press | News | Comments

As Ebola-related quarantine policies have arisen around the United States, some health workers are reassessing whether, or how long, they can be among the hundreds that officials said are needed to fight the outbreak. Read more...     



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.